Detalhe da pesquisa
1.
Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies.
Int J Mol Sci
; 22(3)2021 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513799
2.
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.
Int J Cancer
; 144(10): 2613-2624, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488605
3.
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors.
Amino Acids
; 51(8): 1177-1185, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240409
4.
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.
Cells
; 11(5)2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269416
5.
Hepatocellular Carcinoma: A Difficult Cancer to Treat.
Crit Rev Oncog
; 26(2): 11-25, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347970
6.
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma.
Cancer Lett
; 519: 250-262, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314755
7.
Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference.
J Biomed Nanotechnol
; 14(5): 1009-1016, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29883570
8.
Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
OMICS
; 22(4): 274-282, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29584564
9.
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.
Cell Death Dis
; 9(2): 28, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348495
10.
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
Adv Biol Regul
; 65: 59-76, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619606
11.
Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
J Control Release
; 266: 47-56, 2017 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28917533
12.
Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
J Agric Food Chem
; 65(7): 1342-1352, 2017 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111949
13.
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
Cell Cycle
; 15(4): 573-83, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26794644
14.
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Int J Pharm
; 493(1-2): 75-85, 2015 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26211902
15.
Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine] manganese(III)chloride.
Int J Oncol
; 38(3): 693-700, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21206968